- EGFR Signaling Pathway
- TGF-beta Signaling
- Canonical Wnt Signaling
- non-Canonical Wnt Signaling
- Notch Signaling
- p53 Pathway
- NF-kB Pathway
- Cytokine Signaling
>Human Cell Expressed
>Mouse IL1R2 / CD121b Protein (His Tag)
|Catalog||Size (Price)||Quantity||In Stock||Operation|
Interleukin 1 receptor, type II Protein Datasheet
IL1R2 / CD121b Protein Price Inquiry ( Available Sizes )
- ≥1mg Bulk: Inquiring Price
IL1R2 / CD121b Protein Product Information
|Synonym :||IL1R2, Il-1r2, Il1rb|
A DNA sequence encoding the mouse IL1R2 (P27931) (Met1-Glu355) was expressed with a C-terminal polyhistidine tag.
|Expression Host:||Human Cells|
IL1R2 / CD121b Protein QC Testing
|Purity:||>95% as determined by SDS-PAGE||SDS-PAGE:
IL1R2 / CD121b protein
|Measured by its binding ability in a functional ELISA.
Immobilized mouse IL1R2-His at 10 μg/ml (100 μl/well) can bind biotinylated human IL1B-His (Cat:10139-H07E), The EC50 of biotinylated human IL1B-His (Cat:10139-H07E) is 0.37-0.85 μg/ml.
|Endotoxin:||< 1.0 EU per μg of the protein as determined by the LAL method|
|Stability:||Samples are stable for up to twelve months from date of receipt at -70℃|
|Predicted N terminal:||Phe 14|
The recombinant mouse IL1R2 comprises 353 amino acids and has a predicted molecular mass of 39.6 kDa. The apparent molecular mass of the protein is approximately 56 kDa in SDS-PAGE under reducing conditions due to glycosylation.
|Formulation:||Lyophilized from sterile PBS, pH7.4.
IL1R2 / CD121b Protein Usage Guide
|Storage:||Store it under sterile conditions at -70℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.|
|Reconstitution:||A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.|
IL1R2 / CD121b Protein Related Products & Topics
|Molecule||Species||Description //For Detailed Info. and Price------CLICK!||Cat. No|
|IL-1R2/CD121b||Human||IL-1R2/CD121b/Fc Protein, Recombinant||10111-H02H|
|IL-1R2/CD121b||Human||IL-1R2/CD121b Protein, Recombinant||10111-H08H|
|IL-1R2/CD121b||Mouse||IL1R2 / CD121b Protein, Recombinant||51090-M02H|
|IL-1R2/CD121b||Mouse||IL1R2 / CD121b Protein, Recombinant||51090-M08H|
|IL-1R2/CD121b||Rat||IL1R2 / IL1RB / CD121b Protein, Recombinant||80196-R02H|
|IL-1R2/CD121b||Rat||IL1R2 / IL1RB / CD121b Protein, Recombinant||80196-R08H|
|IL-1R2||Cynomolgus||IL1R2 / IL1RB Protein, Recombinant||90120-C02H|
|Molecule||Application||Description //For Detailed Info. and Price------CLICK!||Cat. No|
|WB||IL-1R2/CD121b Antibody, Mouse Mab||10111-MM09|
|WB, ELISA||IL-1R2/CD121b Antibody, Rabbit MAb||10111-R020|
|WB, ELISA||IL-1R2/CD121b Antibody, Rabbit PAb||10111-RP01|
|WB, ELISA||IL-1R2/CD121b Antibody, Rabbit PAb (Antigen Affinity Purified)||10111-RP02|
|WB, ELISA||IL-1R2/CD121b Antibody, Mouse MAb||10111-MM04|
IL1R2 / CD121b Protein Description
The pleiotropic cytokine IL1 is produced to regulate development and maintenance of the inflammatory responses, and binds to specific plasma membrane receptors on cells. Two distinct types of IL1 receptors which are able to bind IL1 specifically have been identified, designated as IL1RI (IL1RA) and IL1RII (IL1RB). A closely related receptor-like chain IL1R accessory protein (IL1RAcP) has been reported to heterodimerize with the IL1RI to form the signal transduction complex which appears to mediate all the known IL1 signal processes. IL1RII structurally consisting of a ligand binding portion comprised of three Ig -like domains, a single transmembrane region, and a short cytoplasmic domain, is expressed in a variety of cell types including B lymphocytes, neutrophils, monocytes, large granular leukocytes and endothelial cells. Like the IL1RI, the human IL1RII can bind all three forms of IL1 (IL1 alpha, IL1 beta and IL1ra) but does not transmit IL1 signals. In addition to the membrane-bound form, IL1RII also exists as the soluble form, and either acts as a decoy receptor that inhibits IL1 action by blocking the binding of IL1 to the type I receptor complex. Furthermore, IL4 is reported to antagonize the activity of IL1 by inducing the expression and release of this cytokine. Recombinant soluble IL1RII is thus a potent antagonist of IL1 action, and serves as a potential therapeutic target.
- McMahan CJ. et al., 1991, EMBO J. 10: 2821-32.
- Liu C. et al., 1996, J Biol Chem. 271: 20965-72.
- Rauschmayr T. et al., 1997, Proc Natl Acad Sci. 94: 5814-19.
- Neumann D. et al., 2000, J. Immunol. 165: 3350-7.
- Colotta F. et al., 1993, Science. 261: 472-5.
|Interleukin / Interleukins|